FDA NDC Directory · JSON-LD · Markdown

RETROVIR

NDC 49702-212 · HUMAN PRESCRIPTION DRUG · SOLUTION

Generic namezidovudine
Labeler / ManufacturerViiV Healthcare Company
Marketing categoryNew Drug Application (innovator) · App NDA019910
Dosage form / routeSOLUTION · ORAL
Active ingredientsZIDOVUDINE (10 mg/mL)
Marketing started20101028
Package count1

External sources

Source: openFDA. Public-domain (CC0).